ArticleScientific reports2024

Inhibition of NLRP3 inflammasome contributes to paclitaxel efficacy in triple negative breast cancer treatment.

Liliana-Roxana Balahura Stămat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.